Taking stock of the drug industry, from the lab to the medicine chest

January 10, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

FDA Patrizia Cavazzoni, head of FDA's drug center, to leave the agency Public health experts have expressed concern that longtime FDA staff may leave due to fears of working in an antagonistic environment By Lizzy Lawrence and Adam Feuerstein STAT+ | Spurred by AI's possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund The drugmaker and the venture capital firm will look at new technologies in the "biotech ecosystem," with a focus on artificial intelligence. By Matthew Herper In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways In new guidance, the agency mentions lifestyle interventions less than previously and takes a less conservative view of how drugs should be tested in kids. By Elaine Chen Adobe STAT+ | Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease Funding for the company, which will focus on targeted drugs for heart disease, comes from Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage. By Matthew Herper STAT+ | Opinion: Why isn't AI transforming biopharma as fast as we'd like?    The essential nature of our industry adds further friction to AI transformation, writes Bristol Myers Squibb's chief digital and technology officer. By Greg Meyers STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser